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Fetal stem cells differ phenotypically and func-
tionally from adult stem cells in diverse tissues.
However, little is known about how these differ-
ences are regulated. To address this we com-
pared the gene expression profiles of fetal ver-
sus adult hematopoietic stem cells (HSCs) and
discovered that the Sox17 transcriptional regu-
lator is specifically expressed in fetal and neo-
natal but not adult HSCs. Germline deletion of
Sox17 led to severe fetal hematopoietic de-
fects, including a lack of detectable definitive
HSCs. Conditional deletion of Sox17 from he-
matopoietic cells led to the loss of fetal and
neonatal but not adult HSCs. HSCs stopped ex-
pressing Sox17 approximately 4 weeks after
birth. During this transition, loss of Sox17 ex-
pression correlated with slower proliferation
and the acquisition of an adult phenotype by in-
dividual HSCs. Sox17 is thus required for the
maintenance of fetal and neonatal HSCs and
distinguishes their transcriptional regulation
from adult HSCs.
INTRODUCTION
Stem cells undergo discrete developmental changes
throughout life but little is known about how these transi-
tions are regulated. A particularly profound transition oc-
curs between fetal development and adulthood, when
stem cells from diverse tissues undergo changes in phe-
notype, function, and regulation (Molofsky et al., 2004).
This raises the possibility that transcriptional programs
that maintain stem cell identity and function change be-
tween fetal and adult life.
One cardinal feature of stem cells that changes with de-
velopment is self renewal. Even self-renewal mechanisms
that are broadly conserved among tissues fail to be main-
tained across developmental time (Molofsky et al., 2004).470 Cell 130, 470–483, August 10, 2007 ª2007 Elsevier Inc.Oct4 and Nanog are required for the self renewal of em-
bryonic stem cells but not fetal or adult somatic stem cells
(Nichols et al., 1998; Chambers et al., 2003; Mitsui et al.,
2003). Bmi-1 is required for the self renewal of every post-
natal stem cell yet examined, including HSCs and neural
stem cells, but it is not required in vivo for the self renewal
of fetal stem cells in the same tissues (Lessard and Sauva-
geau, 2003; Molofsky et al., 2003; Park et al., 2003). Ink4a
expression cannot be detected in fetal or young adult
stem cells but increases with age in stem cells from di-
verse tissues, reducing self renewal potential and regener-
ative capacity (Janzen et al., 2006; Krishnamurthy et al.,
2006; Molofsky et al., 2006). While a great deal has been
learned about embryonic and adult stem cell self renewal,
comparatively less is known about mechanisms that spe-
cifically maintain fetal stem cells.
Developmental changes in the properties of stem cells
have been best described in hematopoiesis (Mikkola
and Orkin, 2006). Fetal HSCs differ from adult HSCs in
gene expression (Phillips et al., 2000; Ivanova et al.,
2002), marker expression (Morrison et al., 1995; Kim
et al., 2005), developmental potential (Ikuta et al., 1990;
Kantor et al., 1992), self-renewal potential (Morrison
et al., 1995; Harrison et al., 1997), and regulation (Park
et al., 2003; Hock et al., 2004a, 2004b). HSCs transition
from fetal to adult properties 3–4 weeks after birth, when
HSCs suddenly become quiescent (Bowie et al., 2006).
It is not clearwhat regulates the unique properties of fetal
HSCs. A number of genes including Scl (Porcher et al.,
1996), Aml-1/Runx1 (Okuda et al., 1996; Wang et al.,
1996), Lmo2 (Warren et al., 1994), Gata-2 (Tsai
et al., 1994), cdx4 (Davidson et al., 2003), and mixed-line-
age leukemia (Ernst et al., 2004) are required embryonically
for the formation of HSCs. However, with the exception of
Gata-2, there is little evidence that these genes play any
ongoing role in the maintenance of HSCs after formation
(Mikkola and Orkin, 2006). For example, Scl and Aml-1/
Runx1 are dispensable for the maintenance of HSCs, at
least in adulthood (Mikkola et al., 2003; Ichikawa et al.,
2004). Other genes appear to regulate the maintenance of
HSCs throughout fetal and adult life including Rae28
(Ohta et al., 2002; Kim et al., 2004), Meis1 (Hisa et al.,
2004; Kirito et al., 2004; Azcoitia et al., 2005), c-myb (Mu-
censki et al., 1991; Sandberg et al., 2005), and Cbp (Rebel
et al., 2002). However, to our knowledge no gene is known
to regulate the maintenance of fetal but not adult HSCs. In
contrast, a number of transcriptional regulators maintain
adult but not fetal HSCs, including Gfi-1 (Hock et al.,
2004a), Tel/Etv6 (Hock et al., 2004b), and Bmi-1 (Park
et al., 2003). This raises the question of what transcriptional
regulators act downstream of Scl and Aml-1/Runx1 to reg-
ulate fetal HSC identity andmaintenance prior to the onset
of the adult HSC self-renewal program.
Sry-related high mobility group box (Sox) transcription
factors contain a DNA-binding domain (the HMG box)
and regulate stem cell identity and function in multiple tis-
sues (Schepers et al., 2002). Sox17 has been used as
a marker of endodermal identity (Yasunaga et al., 2005)
and is required for the formation and maintenance of en-
doderm (Hudson et al., 1997; Kanai-Azuma et al., 2002)
and vascular endothelium (Matsui et al., 2006). But Sox
family members have never been implicated in the regula-
tion of HSCs. Here we report that within the hematopoietic
system Sox17 is highly restricted in its expression to fetal
and neonatal HSCs and is required for the maintenance of
fetal and neonatal, but not adult HSCs. Sox17 is thus
a marker of fetal identity in HSCs and distinguishes their
transcriptional regulation from adult HSCs.
RESULTS
In this studywe reexamined previously published gene ex-
pression profiles of highly purified fetal (Kiel et al., 2005a)
and adult (Kiel et al., 2005b) mouse HSCs to identify genes
that were more highly expressed in fetal as compared to
adult HSCs. Sox17 was clearly detected in embryonic
day (E)14.5 fetal liver HSCs, but not in CD45+ fetal liver he-
matopoietic cells, young adult bone marrow HSCs, young
adult bone marrow CD45+ cells, or old adult bone marrow
HSCs (Figure S1). We confirmed this by quantitative real-
time RT-PCR (Figure S1). We hypothesized that Sox17
regulates fetal HSC identity or function.
Generation of Sox17-Deficient Mice
To test whether Sox17 regulates fetal HSCs we generated
Sox17 knockout mice. The entire coding sequence of
Sox17 was replaced with the gene encoding enhanced
green fluorescence protein (eGFP), in frame with the
Sox17 start codon, by homologous recombination
(Figures 1A and 1B). Two mouse lines were generated us-
ing independently targeted ES cell lines, both of which
gave germline transmission of Sox17GFP alleles. We could
not detect mRNA that contained the Sox17 coding se-
quence in Sox17GFP/GFP mice by RT-PCR (Figure 1C).
Sox17GFP/GFPmice from both lines showed severe growth
retardation relative to littermate controls by E11.5, as well
as posterior patterning and body axis rotation defects
(Figure 1D). In both lines, Sox17GFP/GFP mice were ob-
served in expected ratios through E12.5 but died by
E13.5 (Figure 1E). This phenotype is consistent with thatof independently targeted Sox17-deficient mice that also
died embryonically with growth retardation and posterior
patterning defects (Kanai-Azuma et al., 2002).
Sox17 Deficiency Severely Reduces Fetal
Hematopoiesis
In addition to recapitulating the previously described
gross phenotypes associated with Sox17 deficiency, we
observed a severe defect in fetal hematopoiesis that
was not reported previously. Sox17GFP/GFP mice had
some blood cells and hemorrhaging but did not develop
visible hematopoiesis as observed in control littermates
(Figures 1D and 2B). This failure of hematopoiesis affected
the yolk sac (Figure 2A) as well as the fetal liver (Figure 2B)
as both structures were pale in Sox17GFP/GFP mice.
Sox17GFP/GFP mice had significantly (p < 0.05) fewer
CD45+ blood cells and Ter119+ erythroid cells in both
the yolk sac and whole embryo as compared to littermate
controls (Figure 2C). Sox17GFP/GFP mice also exhibited
significantly fewer colony-forming progenitors in yolk
sac and whole embryo (CFU-C) (Figure 2D). All types of
CFU-Cwere similarly reduced in number (data not shown).
The fact that these defects were most severe intraem-
bryonically suggests that Sox17 is particularly important
for definitive hematopoiesis.
In the Hematopoietic System Sox17 Is Mainly
Expressed by Fetal and Neonatal HSCs
To determine how broadly Sox17 is expressed we exam-
ined GFP fluorescence in Sox17GFP/+ mice. Only 0.5% of
E14.5 fetal liver cells were GFP+, and this percentage de-
clined over time, with only 0.2% GFP+ cells in bone mar-
row from 2-week-old mice and levels similar to back-
ground in bone marrow from 4- and 8-week-old mice
(Figure 3A).
To examine GFP expression in fetal HSCs we examined
Sca-1+LineageMac-1+CD48 cells from E14.5 fetal liver,
which represented 0.030 ± 0.006% of fetal liver cells in
these experiments. These cells include all fetal liver HSC
activity and are highly enriched for HSCs (Kim et al.,
2006). Ninety-four percent (two percent standard devia-
tion) of Sca-1+LineageMac-1+CD48 cells were GFP+ in
Sox17GFP/+ mice (Figure 3B). To functionally test whether
all E14.5 fetal liver HSCs express Sox17, we transplanted
1,000 GFP+ fetal liver cells or 199,000 GFP fetal liver cells
from Sox17GFP/+ mice into irradiated recipient mice in
a competitive reconstitution assay. All 12 of themice trans-
plantedwith GFP+ cells showed long-termmultilineage re-
constitution by donor cells, while none of 11 mice trans-
planted with GFP cells showed any donor cell
reconstitution (Figure 3C). These data demonstrate that
all, or virtually all, fetal liver HSCs express Sox17.
To examine GFP expression in postnatal bone marrow
HSCs, we examined Sca-1+Lineagec-kit+CD48 cells
from the bone marrow of 2-, 4-, and 8 week-old mice.
These cells represented 0.019% ± 0 .004% of bone mar-
row cells at 2 weeks but fell to 0.004% ± 0.0004% of bone
marrow cells by 8 weeks of age. This population containsCell 130, 470–483, August 10, 2007 ª2007 Elsevier Inc. 471
Figure 1. Generation of Sox17GFP/GFP
Mice
(A) Schematic representation of the Sox17 tar-
geted allele. The genomic structure after neo-
cassette removal is shown on the fourth line.
B and R indicate BamHI and EcoRV digestion
sites, respectively.
(B) Genotypes of heterozygous F1mice (before
neo excision) and F2 mice (after neo excision)
from two independent lines were confirmed
by Southern blot. Tail genomic DNA was di-
gested with EcoRV and BamHI for 50 and 30
probe hybridization, respectively.
(C) The lack ofSox17expression inSox17GFP/GFP
embryos from both lines of mice was con-
firmed by RT-PCR using primers that amplified
the Sox17 50 untranslated region (which was
expressed from the targeted allele), the coding
sequence (not expressed), and the Sox17 30
untranslated region (not expressed).
(D) At E11.5, Sox17GFP/GFP embryos were
much smaller than Sox17GFP/+ embryos and
exhibited severe defects in posterior pattern-
ing (arrow) and body axis rotation (arrow-
heads).
(E) Genotypes of progeny from Sox17GFP/+ in-
tercrosses revealed Mendelian inheritance up
to E12.5 but loss of Sox17-deficienct embryos
by E13.5.all of the detectable HSC activity in adult bonemarrow and
is highly enriched for HSCs (Kiel et al., 2005b; Yilmaz et al.,
2005). While 86% ± 5% of bone marrow Sca-1+Line-
agec-kit+CD48 cells in 2-week-old mice expressed
GFP, this percentage dropped to 50% ± 8% in 4-week-
old mice and to undetectable levels in 8-week-old mice
(Figure 3B).Sox17 thus continues to be expressed by neo-
natal, but not adult, HSCs.
Some CFU-C also expressed Sox17 in the fetal liver. All
cells that formed CFU-GEMM colonies (containing granu-
locytes, erythrocytes, macrophages, and megakaryo-
cytes) in culture arose from GFP+ fetal liver cells, as did
65% ± 2% of all colony-forming progenitors (CFU-C)
from fetal liver (data not shown). By 2 weeks after birth,
only 18% ± 4% of CFU-GEMM and 9% ± 3% of all
CFU-C arose from GFP+ bone marrow cells. We have
not been able to detect GFP+ bone marrow cells in adults
(Figure 3A). Sox17 is thus expressed by fetal and neonatal
HSCs as well as some downstream progenitors.472 Cell 130, 470–483, August 10, 2007 ª2007 Elsevier Inc.To test whether Sox17 expression is induced in prolif-
erating adult HSCs we treated adult Sox17GFP/+ mice
with cyclophosphamide/G-CSF (Morrison et al., 1997).
Although HSCs were driven into cycle, expanded in
number, and mobilized after cyclophosphamide/G-CSF
treatment, GFP was not expressed by HSCs in the
bone marrow or the spleen (Figure S2). This indicates
that Sox17 is not simply expressed by dividing HSCs
and cannot be induced in adult HSCs by proliferation
or mobilization.
Sox17 Is Required for the Generation orMaintenance
of Fetal HSCs
To test whether Sox17 is required for HSC function dur-
ing fetal development we generated E12.5 Sox17+/+,
Sox17GFP/+, or Sox17GFP/GFP embryos and transplanted
yolk sac, fetal liver, or dissociated cells from the rest of
the embryo into irradiated recipients in competitive re-
constitution assays. Each CD45.1+ recipient mouse was
Figure 2. Sox17 Is Required for Hemato-
poiesis in the Fetal Liver and Yolk Sac
The yolk sac (A) and fetal liver (B) of E11.5 em-
bryos contained obvious blood cells in
Sox17GFP/+ embryos but not in Sox17GFP/GFP
littermates. The numbers of CD45+ hematopoi-
etic cells and Ter119+ erythroid cells in E11.5
yolk sac and whole embryo were significantly
(*, p < 0.05) reduced in Sox17GFP/GFP embryos
as compared to Sox17GFP/+ and Sox17+/+ em-
bryos (C, three independent experiments). The
numbers of colony-forming progenitors (CFU-
C) in E11.5 yolk sac and whole embryo were
also significantly (#, p < 0.01) reduced in
Sox17GFP/GFP embryos as compared to
Sox17GFP/+ and Sox17+/+ embryos (D, three in-
dependent experiments).transplanted with all of the yolk sac, liver cells, or remain-
ing embryo cells from a single CD45.2+ donor embryo.
The livers of Sox17GFP/GFP embryos were so hypocellular
and pale that the entire embryos were dissociated and
transplanted, rather than just fetal liver. Most of the recip-
ients that were transplanted with liver, yolk sac, or other
cells from Sox17+/+ or Sox17GFP/+ embryos became
long-term multilineage reconstituted by donor cells (Fig-
ures 3D and 3E). In contrast, none of the recipients trans-
planted with cells from Sox17GFP/GFP embryos ever be-
came reconstituted by donor cells. Sox17 is thus
required for the generation or maintenance of definitive
HSCs.Sox17 Is Required within the Hematopoietic/
Endothelial Lineages for HSCs
To test whether Sox17 is required autonomously for the
generation ormaintenance of HSCswe generated a floxed
allele (Sox17fl) for the conditional deletion of Sox17 (Fig-
ures 4A–4C). The Sox17fl allele provided normal Sox17
function prior to recombination as Sox17fl/GFP mice (lack-
ing Cre) were born in expected numbers and appeared
developmentally normal (Figure 4F). Moreover, inter-
crosses between Sox17fl/+ mice led to the birth of
Sox17fl/fl mice in expected numbers (Figure S3). Sox17fl/fl
mice were developmentally normal, had normal blood cell
counts, and were fertile (Figure S3).Cell 130, 470–483, August 10, 2007 ª2007 Elsevier Inc. 473
Figure 3. Sox17 Is Expressed by, and Required for the Maintenance of, Fetal and Neonatal But Not Adult HSCs
(A) Sox17 expression in fetal liver or bonemarrow cells was analyzed by flow cytometry in Sox17GFP/+mice (five independent experiments). Cells from
Sox17+/+ mice established background. Less than 1% of fetal liver and neonatal bone marrow cells expressed Sox17 (green boxes).
(B) HSCs were isolated from fetal liver as Sca-1+lineageMac-1+CD48 cells and from bone marrow as Sca-1+lineagec-kit+CD48 cells. Most fetal
liver and neonatal bone marrow HSCs expressed Sox17, but expression began to decline by 4 weeks of age and was no longer evident at 8 weeks of
age (five independent experiments).474 Cell 130, 470–483, August 10, 2007 ª2007 Elsevier Inc.
Figure 4. Conditional Deletion of Sox17
in Hematopoietic/Endothelial Cells
Leads to Severe Hematopoietic Defects
and Lethality by E13.5
(A) Targeting of Sox17 to generate a floxed al-
lele. Arrows indicate the sites in the wild-type
allele (Sox17+) where loxP elements were in-
serted. These sites were selected to avoid dis-
rupting conserved sequences (potential regu-
latory elements). Note that Cre-mediated
recombination removes the entire Sox17 cod-
ing sequence.
(B)ThegenotypesofheterozygousF1 (Sox17fl-neo)
and F2 (Sox17fl) mice from two independent
lines were verified by Southern blot. Genomic
tail DNA was digested with EcoRV (R) and
SalI (Sl) for the 50 probe and with SacI (S) for
the 30 probe.
(C) The lack of Sox17 expression in CD144+
endothelial cells sorted from E10.5 Tie2-
Cre+Sox17fl/GFP embryos was confirmed by
RT-PCR using primers that amplified the
Sox17 50 untranslated region (expressed from
the targeted allele), the coding sequence (not
expressed) and the Sox17 30 untranslated re-
gion (not expressed).
(D) E12.5 Tie2-Cre+Sox17fl/GFP embryos were
pale and growth retarded and lacked visible
hematopoiesis.
(E) Unlike control embryos, the yolk sac from
E12.5 Tie2-Cre+Sox17fl/GFP embryos lacked
visible hematopoiesis.
(F) Progeny derived from mating Tie2-
Cre+Sox17GFP/+ males with Sox17fl/fl females:
conditional deletion of Sox17 using Tie2-Cre
was lethal by E13.5.To test whether Sox17 was required within the hemato-
poietic/endothelial lineages for the generation of HSCs we
conditionally deleted Sox17 in endothelial and hematopoi-
etic progenitors using Tie2-Cre (Koni et al., 2001). Tie2-
Cre mice express Cre recombinase in endothelial cells
and HSCs during embryonic development (Schlaeger
et al., 2005; Li et al., 2006). E12.5 Tie2-Cre+Sox17fl/GFP
embryos were growth retarded and lacked visible hema-topoiesis in the liver and yolk sac, but did not have the
obvious posterior patterning or axial turning defects ob-
served in Sox17GFP/GFP embryos (Figures 4D and 4E).
Like Sox17GFP/GFP embryos, Tie2-Cre+Sox17fl/GFP em-
bryos were observed in expected numbers through
E12.5 but were dead by E13.5 (Figure 4F).
The numbers of CD45+, Ter119+ cells (Figure 5A), and
CFU-C (Figure 5B) were also dramatically reduced in the(C) Irradiated mice were transplanted with 1,000 GFP+ fetal liver cells (green lines) or 199,000 GFP fetal liver cells (red lines) from E14.5 Sox17GFP/+
donor mice. All mice transplanted with GFP+ cells were long-term multilineage reconstituted by donor cells (n = 12; each line represents a single
mouse) but none of the mice transplanted with GFP cells showed detectable reconstitution (n = 11 mice; the black line at 0.3% represents back-
ground).
(D) Irradiated recipient mice were transplanted with unfractionated fetal liver, yolk sac, or remaining embryo cells from single E12.5 Sox17+/+,
Sox17GFP/+, or Sox17GFP/GFP embryos. Numbers indicate the fraction of recipient mice that were long-term multilineage reconstituted (>16 weeks)
by donor cells.
(E) While control cells usually gave long-termmultilineage reconstitution (blue and green lines), we never detected any reconstitution by Sox17GFP/GFP
cells (red lines).Cell 130, 470–483, August 10, 2007 ª2007 Elsevier Inc. 475
Figure 5. Conditional Deletion of Sox17
Using Tie2-Cre Leads to a Failure to Gen-
erate or Maintain HSCs
The numbers of CD45+ or Ter119+ cells (A) and
colony-forming progenitors (CFU-C; B) were
dramatically reduced in the yolk sac and em-
bryo of E11.5 Tie2-Cre+Sox17fl/GFP mice as
compared to littermate controls (*, p < 0.05;
#, p < 0.01; four independent experiments).
(C) Irradiated wild-typemice were transplanted
with unfractionated fetal liver, yolk sac, or
remaining embryo cells from single E12.5
Tie2-Cre+Sox17fl/GFP embryos or littermate
controls. The livers of Tie2-Cre+Sox17fl/GFP
embryos were so hypocellular and pale that
the entire embryos were dissociated and trans-
planted, rather than just fetal liver. Numbers in-
dicate the fraction of recipient mice that were
long-term multilineage reconstituted by donor
cells.
(D) While control cells usually gave long-term
multilineage reconstitution (blue and green
lines), we never detected any reconstitution
above background (0.3%) from Tie2-
Cre+Sox17fl/GFP cells (red lines).
(E) CFU-GEMMcolonies fromE11.5Sox17fl/GFP
and Tie2-Cre+Sox17fl/GFP yolk sac were similar
in size and appearance.
(F) Sox17 deletion also did not affect the pro-
portions of colony types, though the absolute
number of all colonies was reduced (three in-
dependent experiments).
(G) E11.5 Tie2-Cre+Sox17fl/GFP and Sox17fl/GFP
yolk sac cells expressed embryonic (ß-H1) and
adult (ß-major) hemoglobin in vivo. In culture,
all colonies from Sox17fl/GFP yolk sac (19/19)
and Tie2-Cre+Sox17fl/GFP yolk sac (20/20) ex-
pressed adult hemoglobin (b-major). PCR on
genomic DNA from individual colonies demon-
strated that 95% of Tie2-Cre+Sox17fl/GFP colo-
nies (19/20) had completely recombined
Sox17 (data not shown).yolk sac and embryo of E11.5 Tie2-Cre+Sox17fl/GFP mice
as compared to controls. As in germline knockouts, these
defects were most severe intraembryonically. Tie2-
Cre+Sox17fl/GFP embryos also lacked any reconstituting
activity when yolk sac or embryo cells were transplanted
into irradiated mice, in contrast to littermate controls
(Figure 5C). Sox17 is thus required in endothelial/hemato-
poietic cells for the generation ormaintenance of definitive
HSCs.
Sox17-Deficient Progenitors Can Differentiate
Normally and Form Definitive Erythrocytes
To test whether Sox17-deficient hematopoietic progeni-
tors were blocked in their ability to differentiate or to tran-
sition from primitive to definitive hematopoiesis, we exam-
ined the rare colonies that arose in culture from E11.5476 Cell 130, 470–483, August 10, 2007 ª2007 Elsevier Inc.Tie2-Cre+Sox17fl/GFP yolk sac cells. Although the number
of colonies was significantly reduced as compared to lit-
termate controls (Figure 5B), the types of colonies that
formed, the size of colonies, their appearance, and their
composition did not differ between Tie2-Cre+Sox17fl/GFP
mice and controls (Figures 5E and 5F). Flow-cytometric
analysis revealed normal numbers of Ter119+ erythrocytes
and Mac-1+ myeloid cells within colonies from Tie2-
Cre+Sox17fl/GFPmice (data not shown). RT-PCR on freshly
dissected, uncultured yolk sac cells revealed both embry-
onic (ß-H1) and adult (ß-major) hemoglobin expression
from wild-type and Tie2-Cre+Sox17fl/GFP yolk sac cells in
vivo (Figure 5G). All colonies from Tie2-Cre+Sox17fl/GFP
mice and controls expressed adult but not embryonic
hemoglobin (Figure 5G). Thus, hematopoietic progenitors
are greatly reduced in number in Tie2-Cre+Sox17fl/GFP
mice but appear to differentiate normally, consistent with
a defect in HSC formation or maintenance.
Sox17 Is Cell-Autonomously Required
for the Maintenance of Definitive HSCs
To test whether Sox17 is required for the ongoing mainte-
nance of HSCs, or just for their initial formation, we ge-
nerated Mx-1-Cre+Sox17fl/GFP mice. We treated new-
born Mx-1-Cre+Sox17fl/GFP mice and littermate controls
(that included both Mx-1-CreSox17fl/GFP and Mx-1-
Cre+Sox17fl/+ mice) with three injections of pIpC on
days 2, 4, and 6 after birth to induce Cre expression
(Hock et al., 2004b). This led to the death of allMx-1-Cre+
Sox17fl/GFP mice by 14 days after birth, while all littermate
controls survived (Figure 6A). In separate experiments,
neonatal Mx-1-Cre+Sox17fl/GFP mice and littermate con-
trols were sacrificed 4–5 days after ending pIpC treatment
to test whether there was any effect on hematopoiesis.
Mx-1-Cre+Sox17fl/GFP mice all exhibited significant (p <
0.05) reductions relative to littermate controls in bonemar-
row cellularity, spleen cellularity, numbers of Flk2Sca-
1+Lineagec-kit+CD48 HSCs, and numbers of CFU-C
in the bone marrow and spleen (Figures 6B–6D). These
mice also had severely reduced thymus cellularity and sig-
nificantly reduced white blood cell and platelet counts
(data not shown). While CFU-C were substantially de-
pleted after Sox17 deletion, the types of colonies they
formed and the appearance and composition of the colo-
nies did not differ from control cells (data not shown). The
depletion of Flk2Sca-1+Lineagec-kit+CD48 HSCs af-
ter Sox17 deletion indicates that Sox17 is required for
the maintenance of HSCs.
To further test if Sox17 is autonomously required for the
maintenance of HSCs, whole bone marrow cells were
transplanted from pIpC-treated neonatal Mx-1-Cre+
Sox17fl/GFP mice or littermate controls into irradiated
wild-type recipients along with wild-type whole bone
marrow cells. Bone marrow cells taken from Mx-1-
Cre+Sox17fl/GFP mice 4–5 days after pIpC treatment ini-
tially gave low levels of multilineage reconstitution, but
multilineage reconstitution could no longer be detected
by 6 weeks after transplantation (Figure 6E). In contrast,
the same dose of bone marrow cells from littermate con-
trols gave high levels of multilineage reconstitution in all
recipients (Figure 6E). By performing PCR on genomic
DNA extracted from individual CFU-GEMM or CFU-GM
colonies that arose from the bone marrow of the donor
mice used in these experiments we determined that
81% of early hematopoietic progenitors from the neonatal
Mx-1-Cre+Sox17fl/GFPmicehaddeletedSox17 (Figure S4).
The failure of Sox17-deficient bone marrow cells to long-
term multilineage reconstitute wild-type recipients
indicates that Sox17 is autonomously required for the
maintenance of neonatal HSCs.
We also tested whether fetal HSCs require Sox17 for
their maintenance in a wild-type environment in a way
that is independent of their ability to home to the bone
marrow after transplantation. We transplanted 200,000unfractionated fetal liver cells from E14.5 Sox17fl/+ or
Mx-1-Cre+Sox17fl/GFP embryos into irradiated wild-type
adult recipients along with a radioprotective dose of
wild-type bone marrow cells. pIpC was administered to
all recipient mice 5, 7, and 9 days after transplantation;
then, the peripheral blood was analyzed 4 weeks after
transplantation. High levels of multilineage reconstitution
were observed from the control (Sox17fl/+) donor cells in
all eight recipient mice: 80% ± 9% of all CD45+ cells
were donor derived in these mice 6 weeks after transplan-
tation (Figure S5). In contrast, none of seven recipient
mice transplanted with Mx-1-Cre+Sox17fl/GFP cells were
stably multilineage reconstituted: only 5% ± 10% of all
CD45+ cells were donor derived 6 weeks after transplan-
tation (Figure S5). Deletion of Sox17 from fetal HSCs
that have already engrafted in a wild-type environment
leads to a near complete loss of reconstituting potential,
indicating that Sox17 is autonomously required for the
maintenance of fetal HSCs.
Since Sox17 expression is extinguished in HSCs around
4 weeks after birth (Figure 3B) we also administered pIpC
to 6-week-old mice to test whether adult HSCs are no lon-
gerSox17dependent. Noneof eightMx-1-Cre+Sox17fl/GFP
mice died, though one of twenty-eight control mice died
(Figure6A). In separateexperiments,Mx-1-Cre+Sox17fl/GFP
mice and littermate controls were sacrificed 1 week af-
ter ending pIpC. We observed no difference between
Mx-1-Cre+Sox17fl/GFP mice and littermate controls in
bone marrow cellularity, spleen cellularity (Figure 6B),
number of Flk2Sca-1+Lineagec-kit+CD48 HSCs in
the bone marrow (Figure 6C), numbers of CFU-C in
the bone marrow (Fig. 6D), or ability of bone marrow
cells to reconstitute irradiated mice (Figure 6E). We
also treated adult Mx-1-Cre+Sox17fl/GFP mice and litter-
mate controls (after pIpC treatment) with cyclophos-
phamide/G-CSF to mobilize HSCs but again detected
no effect of Sox17 deficiency on bone marrow cellular-
ity, spleen cellularity, HSC frequency, or HSC cell cycle
status (Figure S2). By performing PCR on genomic
DNA extracted from colonies that arose in culture
from sorted Flk2Sca-1+Lineagec-kit+CD48 HSCs
we confirmed that 96% of the HSCs from adult Mx-1-
Cre+Sox17fl/GFP mice had deleted Sox17 (Figure S4).
Sox17 is no longer required for adult HSC maintenance,
proliferation, mobilization, or hematopoiesis.
Sox17 Deletion Leads to the Death of Neonatal HSCs
To further investigate the mechanism by which Sox17 de-
letion leads to the loss of HSCs, we examined Sca-1+Lin-
eagec-kit+CD48 HSCs isolated from the bone marrow
of neonatal Mx-1-Cre+Sox17fl/GFP mice or littermate con-
trols 5 days after pIpC treatment. Sox17 deletion had no
immediate effect on the cell cycle distribution of HSCs
(Figure 7A); however, Sox17 deletion did significantly
(p < 0.05) increase the rate of cell death among HSCs
(Figure 7B).
To begin to address the molecular mechanisms by
which Sox17 promotes the maintenance of HSCs, weCell 130, 470–483, August 10, 2007 ª2007 Elsevier Inc. 477
Figure 6. Sox17 Is Autonomously Re-
quired for the Maintenance of Neonatal
But Not Adult HSCs
(A) Mx-1-Cre+Sox17fl/GFP mice and littermate
controls were administered pIpC 2, 4, and 6
days after birth (arrows). All Mx-1-Cre+
Sox17fl/GFP mice died by 14 days after birth,
but no littermate controls died. Adult Mx-1-
Cre+Sox17fl/GFP mice that were administered
seven doses of pIpC over a 14 day period be-
ginning 6 weeks after birth all survived.
(B–C) Four to five days after ending pIpC treat-
ment in neonates and seven days after ending
pIpC treatment in adults, bonemarrow cellular-
ity in the tibias and femurs and spleen cellular-
ity were significantly (*, p < 0.05) reduced in
neonatal Mx-1-Cre+Sox17fl/GFP mice (n = 5–7)
as compared to littermate controls (n = 4–6)
but were not affected in adult Mx-1-
Cre+Sox17fl/GFP mice (n = 4–5) as compared
to littermate controls (n = 4–5). The absolute
numbers of Flk2Sca-1+Lineagec-kit+CD48
HSCs (C) and colony-forming progenitors
(CFU-C; D) in the bone marrow (from tibias
and femurs) and spleen were also significantly
(p < 0.05) reduced in the same neonatal Mx-1-
Cre+Sox17fl/GFP mice but were not affected in
the adult Mx-1-Cre+Sox17fl/GFP mice.
(E) Bone marrow cells from pIpC-treated neo-
natal Mx-1-Cre+Sox17fl/GFP mice (CD45.2+)
failed to give long-termmultilineage reconstitu-
tion in irradiated CD45.1+ wild-type recipients
(n = 5), in contrast to the same dose of cells
from littermates or adult mice (n = 4 or 5; differ-
ences in myeloid, B, and T cell chimerism were
highly statistically significant: #, p < 0.001; 6
week time point is shown). In each case,
200,000 donor bone marrow cells were com-
peted against 200,000 recipient bone marrow
cells.compared the expression of candidate genes by hemato-
poietic progenitors isolated from Sox17-deficient or con-
trol mice. We first tested whether Sox17 was required
for the expression of Runx1, Scl, Gata-2, or Lmo2. How-
ever, all of these genes were expressed at approximately
wild-type levels in both CD45+c-kit+ progenitors and
CD45+c-kit hematopoietic cells from E11.5 Tie2-478 Cell 130, 470–483, August 10, 2007 ª2007 Elsevier Inc.Cre+Sox17fl/GFP embryos and yolk sacs (Figure S6). Sox17
was therefore not required for the expression of genes in-
volved in the formation of HSCs, nor for the expression of
other critical regulators of HSC function including c-Myb
and Gfi-1 (Figure S6). In striking contrast, Dickkopf1 (Dkk1)
expression was dramatically elevated, by 142-fold in
CD45+c-kit+ progenitors from E11.5 Tie2-Cre+Sox17fl/GFP
embryos (Figure S6). Dkk1 expression was also ele-
vated 3.4-fold in the same population from yolk sac.
Since Dkk1 is a powerful negative regulator of Wnt
pathway activation (Glinka et al., 1998) these data raise
the possibility that Sox17 is required to maintain Wnt
signaling in HSCs.
To further explore this possibility we examined gene
expression in c-kit+LineageCD48 hematopoietic pro-
genitors from the bone marrow of neonatal Mx-1-
Cre+Sox17fl/GFP mice or littermate controls 3 days after
pIpC treatment.Outof 15genesexamined, including those
listed above as well as Bmi-1, Etv6, Rae28, Meis1, and
Cpb, the only gene that showedmore than a 2-fold change
in expression afterSox17 deletion wasDkk1 (3.3 ± 0.4-fold
increased expression). Thus Dkk1 expression was ele-
vated in every context in which Sox17 deficiency led to
a loss of HSCs. These data raise the possibility that
Sox17may promote themaintenance of fetal and neonatal
HSCs by promoting Wnt signaling.
Sox17 Expression Is Associated with the
Maintenance of Fetal HSC Properties
To test if the decline in Sox17 expression in wild-type
postnatal HSCs is associated with the acquisition of adult
properties we examined 4-week-old Sox17GFP/+ mice. At
this time HSCs are making the transition from a rapidly
proliferating fetal phenotype to a quiescent adult pheno-
type (Bowie et al., 2006), and approximately 50% of
Sca-1+Lineagec-kit+CD48 HSCs express Sox17
(Figure 3B). To test whether the loss of Sox17 expression
is associated with the loss of the rapidly proliferating phe-
notype, we compared the cell-cycle status of GFP+ and
GFP Sca-1+Lineagec-kit+CD48 cells from Sox17GFP/+
mice. While GFP+ Sca-1+Lineagec-kit+CD48 cells re-
mained rapidly proliferating, with 17% ± 2% of cells in
S/G2/M phase of the cell cycle, GFP Sca-1+Lineagec-
kit+CD48 cells were dividing significantly more slowly,
with only 3% ± 1% of cells in S/G2/M (Figure 7D). This
demonstrates that the loss of Sox17 expression is associ-
ated with the acquisition of a more slowly dividing adult
phenotype.
Figure 7. Sox17 Deletion from Neonatal HSCs Induces Cell
Death, and the Postnatal Decline in Sox17 Expression by
Wild-Type HSCs Is Associated with a Transition to an Adult
Phenotype
(A and B) Sca-1+Lineagec-kit+CD48 HSCs isolated from the bone
marrow of neonatal Mx-1-Cre+Sox17fl/GFP mice 5 days after pIpC
treatment exhibited normal cell-cycle distribution relative to littermate
controls (A) but a 3-fold increased frequency of cells undergoing cell
death (Annexin V+; B).
(C–F) GFP+ (Sox17-expressing) and GFP (Sox17-non-expressing)
Sca-1+Lineagec-kit+CD48 HSCs were isolated from the bone mar-
row of 3.5 to 4 week-old Sox17GFP/+ mice. GFP Sca-1+Lineagec-
kit+CD48 HSCs were dividing less rapidly (D), and failed to express
AA4.1 (E) or Mac-1 (F), consistent with an adult HSC phenotype. In
contrast, GFP+ Sca-1+Lineagec-kit+CD48 HSCs were more rapidly
dividing (D), and expressed AA4.1 (E) and Mac-1 (F), consistent with
a fetal HSC phenotype.Cell 130, 470–483, August 10, 2007 ª2007 Elsevier Inc. 479
To test whether the loss of Sox17 expression is also as-
sociated with the acquisition of an adult surface marker
phenotype, we compared the expression of AA4.1 and
Mac-1 between the GFP+ and GFP fractions of Sca-
1+Lineagec-kit+CD48 cells from Sox17GFP/+ mice.
Mac-1 and AA4.1 are expressed by fetal but not adult
HSCs (Morrison and Weissman, 1994; Morrison et al.,
1995; Phillips et al., 2000). Note that when sorting Sca-
1+Lineagec-kit+CD48 cells from neonatal mice we did
not include Mac-1 in the lineage cocktail. While GFP+
Sca-1+Lineagec-kit+CD48 cells were mainly Mac-1+
and AA4.1+, GFP Sca-1+Lineagec-kit+CD48 cells
were mainly Mac-1 and AA4.1 (Figures 7E and 7F).
This demonstrates that the loss of Sox17 expression is as-
sociated with the acquisition of an adult surface marker
phenotype by HSCs.
DISCUSSION
The discovery that Sox17 maintains fetal but not adult
HSCs fills a critical void in our understanding of HSC reg-
ulation. Prior studies identified genes like Scl, Aml-1/
Runx1, Lmo2, and Gata-2 that are required for the forma-
tion of fetal HSCs (Warren et al., 1994; Okuda et al., 1996;
Porcher et al., 1996; Wang et al., 1996; Mikkola et al.,
2003; Ichikawa et al., 2004), and genes like Gfi-1, Tel/
Etv6, and Bmi-1 that are required for the maintenance of
adult but not fetal HSCs (Park et al., 2003; Hock et al.,
2004a; Hock et al., 2004b). However, we are not aware
of other genes that are required to maintain fetal HSCs
prior to the acquisition of adult HSC properties.
Our data suggest that Sox17 acts downstream of Scl,
Aml-1/Runx1, Lmo2, and Gata-2 to maintain fetal HSCs
prior to the acquisition of an adult phenotype. Quantitative
RT-PCR on RNA fromCD45+c-kit+ hematopoietic progen-
itors from E11.5 Sox17-deficient embryos showed normal
or slightly elevated levels of Scl, Aml-1/Runx1, Lmo2, and
Gata-2 transcripts (Figure S6). This demonstrates that
Sox17 is not required for the expression of Scl, Aml-1/
Runx1, Lmo2, or Gata-2 in embryonic hematopoietic cells
around the time that definitive HSCs are emerging. Sox17
likely acts downstream of these genes to maintain fetal
HSCs after they have formed. Our data do not rule out
a role for Sox17 in the formation of definitive HSCs, but
there are no data that directly support such a possibility
so far.
Sox17 may be required to maintain fetal and neonatal
HSCs by promoting Wnt signaling. Neonatal HSCs under-
went cell death within days of Sox17 deletion (Figure 7B),
and Sox17 deletion dramatically increased Dkk1 expres-
sion in neonatal and embryonic hematopoietic progenitors
(Figure S6). Dkk1 negatively regulates Wnt pathway acti-
vation (Glinka et al., 1998), suggesting that Sox17 deletion
may lead to reduced Wnt signaling in HSCs. Consistent
with this possibility, Sox17 can negatively regulate the ex-
pression of ß-catenin target genes in some contexts (Zorn
et al., 1999; Sinner et al., 2004). Moreover, Wnt3a-defi-
cient mice (Takada et al., 1994) and Tcf4/Tcf1-deficient480 Cell 130, 470–483, August 10, 2007 ª2007 Elsevier Inc.mice (Gregorieff et al., 2004) have posterior patterning de-
fects that are similar to the posterior patterning defect we
observed in Sox17 deficient mice (Figure 1). Wnt pathway
activation has been implicated in the regulation of adult
HSC self renewal (Reya et al., 2003; Willert et al., 2003),
though it may not be necessary (Cobas et al., 2004), and
it is unknown whether Wnt signaling is important for fetal
HSC maintenance. Additional studies will be required to
test whether Sox17 promotes the maintenance of fetal/
neonatal HSCs by promoting Wnt signaling. We also do
not know whether overexpression of Sox17 in adult
HSCs would be sufficient to induce a fetal phenotype.
The identification of Sox17 as a critical regulator of fetal/
neonatal HSCs demonstrates that the transcriptional pro-
grams that maintain HSCs change over time. This implies
that the regulation of stem cell identity may change with
developmental time, perhaps in concert with functional
changes. The discovery that Sox17 is autonomously re-
quired for the maintenance of fetal and neonatal but not
adult HSCs identifies a new stage-specific mechanism
for the maintenance of HSCs that fills a gap between pre-
viously identified mechanisms for the embryonic forma-
tion of HSCs and the maintenance of adult HSCs.
EXPERIMENTAL PROCEDURES
See Supplemental Data for details regarding the generation of Sox17
mutant mice.
Flow Cytometry and Isolation of HSCs
Fetal liver or bonemarrow cells (flushed from tibias and femurs of adult
mice) were triturated with Hank’s Buffered Salt Solution without cal-
cium or magnesium, supplemented with 2% heat-inactivated calf se-
rum (Gibco, Grand Island, NY; HBSS+) and filtered through nylon
screen (45 mm, Sefar America; Kansas City, MO) to obtain a single
cell suspension. To examine the expression of GFP in fetal liver
HSCs (Sca-1+LinMac-1+CD48) and adult bone marrow HSCs
(Sca-1+Linc-kit+CD48), fetal liver cells and bone marrow cells
were stained as previously described (Kiel et al., 2005b; Kim et al.,
2006). Whole fetal liver cells were incubated with unconjugated mono-
clonal antibodies to lineage markers including B220 (6B2), CD3
(KT31.1), CD5 (53-7.3), CD8 (53-6.7), Gr-1 (8C5), and Ter119 (Ter-
119). Pelleted cells were resuspended in anti-rat IgG specific F(ab)2
conjugated to phycoerythrin (PE; Jackson ImmunoResearch; West
Grove, PA). Cells were then stainedwith directly conjugated antibodies
toMac-1 (M1/70-allophycocyanin (APC)), Sca-1 (Ly6A/E-biotin), CD48
(HM48-1-PE), and CD4 (GK1.5-PE), followed by staining with strepta-
vidin conjugated to APC-Cy7 (PharRed; PR) (BD Biosciences; San
Jose, CA). Adult whole bone marrow cells were stained in the same
manner as whole fetal liver cells except that different fluorochromes
were used for Mac-1 (M1/70-PE) and Sca-1 (Ly6A/E-APC), and c-kit
(2B8-biotin) was also included as a marker.
To analyze the expression of GFP in E10.5 or E11.5 embryos, em-
bryos and yolk sacs were separated carefully and digested with colla-
genase type I (1 mg/ml) in the presence of 10% FBS at 37C for 1.5 hr
as previously described (Gekas et al., 2005). Isolated cells were
stained with unconjugated anti-CD144 (clone 11D4.1; BD Bio-
Sciences), whichwas detected by anti-rat IgG-APC (Jackson Immuno-
Research), anti-CD45-biotin (clone 30-F11; eBioscience, San Diego,
CA), and Ter119-PE.
Cells were resuspended in 2mg/ml 7-AAD (Molecular Probes; Eu-
gene, OR) to discriminate live from dead cells. All flow cytometry
was performed on a FACSVantage SE-dual laser, three-line flow cy-
tometer (Becton-Dickinson).
Long-Term Competitive Reconstitution Assays
Recipients in reconstitution assays were adult C57Bl/Ka-CD45.1:Thy-
1.2 mice. Adult recipient mice were irradiated with an Orthovoltage
x-ray source delivering approximately 300 rads/min in two doses of
550–570 rad each, delivered at least 2 hr apart. Transplanted cells
were injected into the retro-orbital venous sinus of individual lethally
irradiated recipients along with 200,000 recipient bone marrow cells
for radioprotection. For at least 16 weeks after transplantation, blood
was obtained from the tail veins of recipient mice, subjected to ammo-
nium-chloride/potassium bicarbonate red cell lysis, and stained with
directly conjugated antibodies to CD45.2 (104), B220 (6B2), Mac-1
(M1/70), CD3 (KT31.1) and Gr-1 (8C5) to monitor donor cell engraft-
ment.
Methylcellulose Culture
Cells were plated in wells of 96-well plates (Corning; Corning, NY) con-
taining 100 ml of 1.0% MethoCult GFM3434 (Stem Cell Technologies;
Vancouver, Canada).
Supplemental Data
Supplemental Data include six figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with
this article online at http://www.cell.com/cgi/content/full/130/3/470/
DC1/.
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